HCA Healthcare Inc (HCA) Position Cut by Amalgamated Bank

Share on StockTwits

Amalgamated Bank trimmed its stake in HCA Healthcare Inc (NYSE:HCA) by 1.4% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 35,568 shares of the company’s stock after selling 499 shares during the quarter. Amalgamated Bank’s holdings in HCA Healthcare were worth $3,450,000 as of its most recent filing with the SEC.

Other institutional investors also recently added to or reduced their stakes in the company. We Are One Seven LLC purchased a new stake in HCA Healthcare in the fourth quarter valued at approximately $110,000. Summit Trail Advisors LLC grew its holdings in HCA Healthcare by 9,933.3% in the first quarter. Summit Trail Advisors LLC now owns 112,774 shares of the company’s stock valued at $113,000 after purchasing an additional 111,650 shares during the period. Parallel Advisors LLC grew its holdings in HCA Healthcare by 76.2% in the fourth quarter. Parallel Advisors LLC now owns 1,337 shares of the company’s stock valued at $117,000 after purchasing an additional 578 shares during the period. Salem Investment Counselors Inc. purchased a new stake in HCA Healthcare in the fourth quarter valued at approximately $130,000. Finally, Verition Fund Management LLC purchased a new stake in HCA Healthcare in the fourth quarter valued at approximately $205,000. Hedge funds and other institutional investors own 70.32% of the company’s stock.

In other news, SVP Kathryn A. Torres sold 1,750 shares of the business’s stock in a transaction on Wednesday, June 13th. The shares were sold at an average price of $106.87, for a total transaction of $187,022.50. Following the transaction, the senior vice president now directly owns 9,494 shares of the company’s stock, valued at $1,014,623.78. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Jonathan B. Perlin sold 25,000 shares of the business’s stock in a transaction on Monday, June 11th. The stock was sold at an average price of $106.00, for a total transaction of $2,650,000.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 39,474 shares of company stock worth $4,161,523. Corporate insiders own 2.80% of the company’s stock.

NYSE HCA opened at $106.74 on Friday. HCA Healthcare Inc has a 52 week low of $71.18 and a 52 week high of $108.85. The company has a debt-to-equity ratio of -7.13, a quick ratio of 1.17 and a current ratio of 1.39. The firm has a market cap of $37.65 billion, a PE ratio of 16.20, a PEG ratio of 1.05 and a beta of 0.51.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, May 1st. The company reported $2.33 EPS for the quarter, topping analysts’ consensus estimates of $2.07 by $0.26. HCA Healthcare had a net margin of 5.96% and a negative return on equity of 55.50%. The business had revenue of $11.42 billion for the quarter, compared to analysts’ expectations of $11.29 billion. During the same period in the previous year, the company posted $1.74 earnings per share. The business’s revenue for the quarter was up 7.5% compared to the same quarter last year. equities research analysts anticipate that HCA Healthcare Inc will post 8.83 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, June 29th. Stockholders of record on Friday, June 1st will be given a dividend of $0.35 per share. The ex-dividend date is Thursday, May 31st. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.31%. HCA Healthcare’s payout ratio is currently 21.24%.

A number of research firms recently issued reports on HCA. Zacks Investment Research downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a report on Tuesday, March 20th. Mizuho began coverage on shares of HCA Healthcare in a report on Friday, March 23rd. They issued a “buy” rating and a $115.00 target price for the company. Four investment analysts have rated the stock with a sell rating, six have assigned a hold rating and sixteen have issued a buy rating to the company. HCA Healthcare currently has an average rating of “Hold” and a consensus target price of $105.95.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply